Test Price
700 AED✅ Home Collection Available
DPYD Genotyping for 5-Fluorouracil (5-FU) Toxicity & Chemotherapeutic Response in UAE | 700 AED | 2026 DHA Guidelines
تحليل فحص جين DPYD للسمية الدوائية لدواء 5-فلورويوراسيل في الإمارات | 700 درهم | معتمد من هيئة الصحة بدبي
✓ 99.9% Diagnostic Sensitivity — ISO 9001:2015 Accredited Molecular Laboratory (Cert: INT/EGQ/2509DA/3139)
✓ Premium Home Collection — Paid hospital-grade cold-chain phlebotomy service across UAE, 8AM–11PM, VIP mobile phlebotomy available
✓ Telephonic Post-Test Guidance — Board-certified clinical pharmacists interpret your DPYD genotype within 3–4 days
✓ Insurance Direct Billing — Verify your policy via WhatsApp: +971 54 548 8731
✓ حساسية تشخيصية بنسبة 99.9% عبر مختبر معتمد ISO 9001:2015
✓ خدمة سحب الدم المنزلي المدفوعة مع سلسلة تبريد معتمدة، متاحة من 8 صباحاً حتى 11 مساءً، وفريق تمريض متنقل
✓ استشارة هاتفية بعد النتيجة مع صيادلة سريريين لتفسير النتائج الجينية
✓ تحقق من تغطية التأمين عبر واتساب: 971545488731+
Overview: DPYD Pharmacogenomic Screening for 5-FU Safety
This Sanger sequencing‑based test detects pathogenic variants in the DPYD gene (e.g., *2A, *13, rs67376798) to predict severe, potentially fatal toxicity from fluoropyrimidine chemotherapy (5‑fluorouracil, capecitabine). Clinicians across Dubai, Abu Dhabi, and Sharjah rely on this pre‑treatment screen to personalise dosing, reduce life‑threatening adverse events, and align with 2026 DHA oncology standards.
Our DPYD Genotyping vs. Other Approaches
| Parameter | Our Test (DHA‑Licensed 9834453) | Common Commercial Panels |
|---|---|---|
| Methodology | Sanger Sequencing + PCR confirmation, gold‑standard for targeted variants | Often mass‑spec genotyping arrays; may miss rare UAE-relevant alleles |
| Turnaround Time | 3‑4 calendar days | 5‑10 business days |
| Clinical Report | CPIC‑level interpretation with dose‑adjustment guidance per phenotype | Often generic variant listing without actionable recommendations |
| Regulatory Compliance | Full UAE PDPL, Federal Decree‑Law No. 41/2024, DHA/MOHAP standards | May lack local data‑privacy certifications |
| Price | 700 AED | Often 1,200‑2,000 AED |
Physician Insight & Safety Protocol
“DPYD genotyping is a cornerstone of precision oncology in the UAE. A normal result does not eliminate toxicity risk entirely—clinical vigilance remains essential. I always correlate genotype findings with baseline blood counts, renal function, and concomitant disease before finalising the 5‑FU starting dose.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011, Specialist in Clinical Genetics & Pharmacogenomics
🚨 Critical Medication Warning
Do not discontinue any prescribed chemotherapy or supportive medication without explicit instruction from your treating oncologist. This test is for pre‑treatment optimisation; altering current therapy without medical oversight may cause disease progression or unacceptable toxicity.
- Exclusion Criteria: Not intended for patients currently in active anaphylaxis, haemodynamic instability, or those unable to give informed consent for genetic testing as per UAE CDS Law 2026.
- Emergency Red Flags after 5‑FU: If you experience sudden severe diarrhoea, fever >38.5 °C, mucositis preventing oral intake, or chest pain, proceed to the nearest emergency department immediately.
- Pre‑Test Requirements: A valid physician prescription is required for DPYD testing, except in cases of elective surgery planning, pregnancy (where fluoropyrimidines are contraindicated), or international travel documentation. Please provide the prescription during home collection or upload via WhatsApp.
Patient FAQ & Clinical Guidance
Why is DPYD testing necessary before starting 5‑FU chemotherapy?
DPYD deficiency can turn standard 5‑FU into a life‑threating event due to severe myelosuppression. Up to 5% of the population carries a high‑risk variant that drastically reduces the enzyme’s activity, leading to profound neutropenia, diarrhoea, and hand‑foot syndrome. Identifying your phenotype allows the oncologist to lower the starting dose by 50% or switch to a non‑fluoropyrimidine regimen, dramatically improving safety while preserving anticancer efficacy. All testing is performed under Federal Decree‑Law No. 41/2024 on genetic data privacy.
لماذا يعتبر فحص جين DPYD ضرورياً قبل بدء علاج 5‑فلورويوراسيل؟
نقص إنزيم DPYD يمكن أن يحوّل الجرعة العادية من 5‑فلورويوراسيل إلى حدث مهدد للحياة بسبب تثبيط نخاع العظم الشديد. تحديد النمط الجيني يسمح لطبيب الأورام بتخفيض الجرعة الأولى بنسبة تصل إلى 50% أو استخدام علاج بديل، مما يقلل من خطر الوفاة المرتبط بالعلاج الكيميائي.
How is the test performed and when will I receive results?
A single peripheral blood draw collected by our cold‑chain phlebotomy team yields your genotype in 3–4 days. No fasting or special preparation is required. The sample is processed in our ISO‑certified molecular lab using Sanger sequencing to detect the four clinically actionable DPYD variants most prevalent in Middle Eastern populations. Results are released via secure patient portal with DHA‑compliant encryption. You may request a 15‑minute telephonic interpretation session with a clinical pharmacist.
كيف يتم إجراء الفحص ومتى أحصل على النتائج؟
يتم سحب عينة دم وريدي واحدة بواسطة فريق التمريض المنزلي المعتمد، وتظهر النتيجة خلال 3 إلى 4 أيام. لا يتطلب الفحص صياماً أو تحضيرات خاصة، وتُحلل العينة بتقنية تسلسل سانجر للكشف عن الطفرات الأربعة الأكثر شيوعاً في الشرق الأوسط.
Will my insurance cover the 700 AED cost?
Most UAE‑based insurers reimburse DPYD genotyping when pre‑authorised as a pharmacogenomic necessity for chemotherapy planning. Coverage is rapidly expanding under the 2026 DHA Mandatory Genetic Testing Guideline for oncology. Send a photo of your insurance card via WhatsApp to +971 54 548 8731, and our billing team will confirm your eligibility and handle direct billing within 2 hours. If self‑pay, the 700 AED includes home collection, cold‑chain logistics, and clinical report.
هل يغطي التأمين تكلفة الفحص البالغة 700 درهم؟
تغطي معظم شركات التأمين في الإمارات فحص DPYD عند الحصول على موافقة مسبقة كضرورة دوائية جينية لتخطيط العلاج الكيميائي. أرسل صورة بطاقة التأمين عبر واتساب إلى 971545488731+ وسنتولى التحقق والموافقة خلال ساعتين.
Regulatory & Accreditation Notices:
هذا الفحص مرخص من هيئة الصحة بدبي (رقم المنشأة 9834453) ويلتزم بالقانون الاتحادي رقم 41 لسنة 2024 بشأن البيانات الجينية وقانون حماية البيانات الشخصية (PDPL).
This service is provided under DHA Facility License No. 9834453 and rigorous adherence to Federal Decree‑Law No. 41 of 2024 on Genetic Data Protection, UAE PDPL, and CDS Law 2026 for minor consent. ISO 9001:2015 Quality Management System (Cert: INT/EGQ/2509DA/3139) guarantees traceable, valid results. All genetic counseling adheres to DHA/MOHAP scope‑of‑practice regulations. LOINC code: 81224-6 (https://loinc.org/81224-6). ICD‑10‑CM 2026 codes mapped to this: Z13.79 (Genetic screening), Z51.11 (Encounter for antineoplastic chemotherapy), T45.1X5A (Adverse effect of antineoplastic drugs—initial encounter).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians